Tag: Protenus


Good News: JHTV Wins Federal Grant to Launch Digital…

Good News: September 2019

Startup news

    • PGDx looking to raise up to $20 million
      “We are growing, innovating and developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide,” the company said in a statement to the Baltimore Business Journal. “To support this growth, we are focused on maintaining our strong balance sheet, securing efficient access to capital and upholding our financial flexibility.”
    • Protenus raises $17M in Series C funding round
      The Series C round was led by LTP, which focuses on investments in health IT and services companies. The health care cybersecurity firm said the money will help to accelerate sales as it looks to partner with health care institutions.
    • How Aidar Health’s 30-Second Breath Test Is Transforming Patient Monitoring
      MouthLab has the potential to transform patient care. When someone breathes into it for 30 seconds, MouthLab records that person’s respiratory rate and pattern, pulse rate, ECG, SpO2 (oxygen saturation), temperature, heart rate, heart rate variability, blood pressure, and spirometric lung functions, making the data immediately available to caregivers, both professional and personal.
    • Erada receives multimillion-dollar grant
      South Africa-based Erada received the funding from De Beers Group. Erada is developing the world’s first ever saliva-based rapid test for diagnosing and identifying malaria, known as Saliva-based Malaria Asymptomatic and Asexual Rapid Test, to be marketed under the brand SALVA! – with the solution due to be launched globally during World Malaria Day in April 2020.

Other news

Anchor Ventures

Real Experts Ponder Future of Artificial Intelligence at Anchor…

Real Experts Ponder Future of Artificial Intelligence at Anchor Ventures Event

April 3, 2019

The machines will not take over civilization anytime soon, but they will be important partners in most aspects of daily life.

This was the consensus among four entrepreneurs who use artificial intelligence in their work and who spoke during Artificial Intelligence: Industry Perspectives and Impacts, the latest event from Anchor Ventures, the TEDCO-funded speaker series run by Johns Hopkins Technology Ventures, the University System of Maryland and the University of Maryland, Baltimore.

“Even with autonomous systems, there are going to be human-machine teams,” said Ashley Llorens, chief of the Intelligent Systems Center at the Johns Hopkins University Applied Physics Laboratory.

Jim Kukla of RedShred, Nick Culbertson of Protenus, radiologist Steven Rothenberg and Ashley Llorens of the Johns Hopkins University Applied Physics Lab during Anchor Ventures’ panel discussion on artificial intelligence.

Llorens kicked off the March 14 panel discussion at the University of Maryland BioPark in Baltimore with an overview of the state of artificial intelligence (AI), which he said “encompasses the aspirations of what we think machines will do for us in the future.”

Right now, however, machines have major limitations. They cannot perceive or use flexible reasoning, work together in teams or make decisions without being given clear boundaries within which to work — all hallmarks of human thinking, according to Llorens.

Machines, in other words, “can do superhuman game play but not superhuman life play,” he told the audience of innovators, entrepreneurs, inventors and ecosystem builders.

In the medical arena, AI already is helping doctors read medical images and prioritize treatments, according to Steven Rothenberg, a radiology resident at the University of Maryland Medical Center.

“There is no better time to be a radiologist,” said Rothenberg. “Humans will remain the stewards of precision medicine” but they will be equipped with better tools.

AI is on the verge of conducting quantitative image analysis, which would provide a more objective diagnosis for a patient, Rothenberg said. The challenge, he continued, is making the economic argument for the technology to hospital administrators.

“There is lots of action in research, but it’s difficult to translate this into the clinical world,” he said.

Among the challenges is patient data privacy. Nick Culbertson, CEO and co-founder of Protenus, a Johns Hopkins alumni startup that protects patient data for health systems, described the “tension” between analyzing data sets to identify and improve inefficiencies and exposing the private data for analysis in the first place.

Protenus adheres to Google’s onetime unofficial motto when balancing this tension: “Don’t be evil.”

“Trust needs to be built” between AI companies and consumers, he added.

That includes watching out for fake content and bias in results, said Jim Kukla, chief technology officer and co-founder of RedShred, a Baltimore startup applying AI to document review and handling.

Bias in AI is “real and measurable,” he said. “It’s a sociological and policy issue as much as a technological one.”

Kukla advocated for as much transparency in the AI industry as possible, noting advancements will keep coming at a rapid pace.

Still, Kukla and the other panelists were confident that all of the innovations would enhance people’s lives, not overtake them.

“AI’s efficiency will prioritize work and free up users’ time,” said Culbertson. “It’s a hybrid to make life easier.”

The next Anchor Ventures event, scheduled for April 25, is the second PowerTEN networking event, during which entrepreneurs, inventors, students and others can spend 10 minutes “ideastorming” with some of the most influential innovators in the Greater Baltimore area. There also will be unscheduled, facilitated networking with other influencers.

To schedule a PowerTEN session, apply here. To attend the unscheduled networking portion of the event, register here.

WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien